Global Molecular Diagnostics Market: Opportunities & Future Forecast analyses the global molecular diagnostics market. The specific clinical segments like Infectious Disease Testing Market, ID/forensics Market, Tissue Typing Market, Oncology Market, Food Testing Market, Genetic Testing Market and Pharmacogenomics Market past, present and future scenario are analyzed in this report. The report provides separate comprehensive past, present and future forecast of molecular diagnostics market on country level as well. Countries covered in the report are: US, Europe and India.

Market Overview

Based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 7 Billion by 2011. The infectious disease was having the biggest market share of 70 percent but gradually its share will decline to 50 percent. The future growth is expected to come from Oncology Testing, Genetic Testing and Pharmacogenomics Testing.

Geographically, the US and European markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However Indian molecular diagnostics market is also catching up fast and future growth is expected from these markets when US and European market will mature. Key player wise molecular diagnostics market is dominated by big companies such as Roche Diagnostics, Gen-Probe, Siemens Healthcare Diagnostics Inc. and Abbott Laboratories which are active in every segment of the clinical diagnostics market. They have broader product portfolios, which can address the needs of any kind of clinical laboratories. However, their leadership is likely to be challenged by the emergence of a new breed of players who target growth areas such as oncology and pharmacogenomics.

Report Forecasts

• What will be the global molecular diagnostics market in 2011?
• What will be the molecular diagnostics market of Europe, India in 2011 and US in 2012?
• What will be the market of Infectious Disease Testing in 2011?
• What will be the market of ID/forensics Market in 2011?
• What will be the market of Tissue Typing Market in 2011?
• What will be the market of Oncology Market in 2011?
• What will be the market of Food Testing Market in 2011?
• What will be the market of Genetic Testing Market in 2011?
• What will be the market of Pharmacogenomics Market in 2011?

Research Highlights

• Global molecular diagnostics market is expected to reach the figure of US$ 7 Billion by 2011.
• US molecular diagnostics market is expected to cross the US$ 4 Billion by 2012.
• European molecular diagnostics market is expected to cross US 1 Billion by 2012.
• India molecular diagnostics market is expected to cross INR 1 Billion by 2011.
• United States and Europe together holds more than 75 percent of molecular diagnostics market in 2008.
• Infectious disease has the highest percentage of market share in 2008 but its share will decline in future.
• Genetic testing is having the second highest market shares in the molecular diagnostics market segment.
• Future prospectus for India molecular diagnostics market an analysis.
• India molecular diagnostics instruments & reagents market for 2007 & 2008

Key Company Profiles

This section provides business overview and key financial information of the companies listed below: Roche Holding Ltd, Abbott, Bayer AG, QIAGEN N.V., Gen-Probe, Becton Dickinson and Company, bioMérieux, Chiron, Myriad Genetics, Inc., Celera.
Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.